Skip to main content
HCPCS J3230 · Level II · Part B drug

HCPCS J3230: Injection, chlorpromazine hcl, up to 50 mg

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: ASP payment limits October 2026 (effective October 1, 2026); MUE and NCCI edits 2026 Q4 (effective October 1, 2026); OPPS Addendum B July 2026 (effective July 1, 2026). Next CMS release: January 1, 2027 (ASP, MUE, NCCI and OPPS quarterly updates).

Key facts for J3230

Billing unit
50 MG
Chlorpromazine hcl injection
ASP payment limit
$16.802
October 2026; -7.4% vs July 2026
Practitioner MUE
2
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J3230 is the Level II code for Injection, chlorpromazine hcl, up to 50 mg, billed per 50 MG. The Medicare Part B ASP payment limit for October 2026 is $16.802 per billing unit, down 7.4% from July 2026. The practitioner MUE allows up to 2 units per date of service (MAI 3). Under OPPS it carries status indicator N. J3230 is billed in units of 50 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 14 NDCs to it, sold as Chlorpromazine HCl, Chlorpromazine Hcl by Henry Schein Inc., Hikma Pharmaceuticals USA Inc., Dr. Reddy's Laboratories Inc.. No current Billing and Coding Article lists J3230, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J3230 at $16.802 per 50 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $18.143 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J3230
QuarterPayment limitPerCoinsurance
October 2026$16.80250 MG20%
July 2026$18.14350 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 14 NDCs from 8 labelers to J3230. Report the NDC in the claim's drug segment and bill the number of J3230 units that equals the quantity administered divided by 50 MG; the last column gives units per full package.

NDCs that crosswalk to J3230
NDCDrug nameLabelerPackage sizeBilling units / package
00404-9836-01Chlorpromazine HClHenry Schein Inc.1 × 11
00641-1397-35Chlorpromazine HClHikma Pharmaceuticals USA Inc.1 × 2513
00641-1398-35Chlorpromazine HClHikma Pharmaceuticals USA Inc.2 × 2525
43598-0140-25Chlorpromazine HclDr. Reddy's Laboratories Inc.1 × 2513
43598-0141-25Chlorpromazine HclDr. Reddy's Laboratories Inc.2 × 2525
51662-1406-01Chlorpromazine HClHF Acquisition Co. LLC, DBA HealthFirst2 × 11
55150-0318-25Chlorpromazine HClEugia US LLC1 × 2513
55150-0319-25Chlorpromazine HClEugia US LLC2 × 2525
65219-0128-01Chlorpromazine HClFreseniUS Kabi USA, LLC1 × 2513
65219-0130-02Chlorpromazine HClFreseniUS Kabi USA, LLC2 × 2525
66794-0249-42Chlorpromazine HClPiramal Critical Care Inc1 × 2513
66794-0250-42Chlorpromazine HClPiramal Critical Care Inc2 × 2525
70710-1849-07Chlorpromazine HClZydus Pharmaceuticals (USA) Inc.1 × 2513
70710-1850-07Chlorpromazine HClZydus Pharmaceuticals (USA) Inc.2 × 2525

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J3230. For practitioners the limit is 2 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J3230 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services23 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital63 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

NCCI edits and add-on relationships

No active practitioner PTP pair lists J3230 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

J3230 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J3230 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the July 2026 OPPS Addendum B, J3230 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for J3230 and how to prevent them

CARC 16 · M119

NDC missing, invalid or not matched to the HCPCS code

CARC 151 · N362

units billed exceed the MUE for the date of service

CARC 50 · N115

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks J3230 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current ASP crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Explore QuickCodeExplore QuickRCMBook a demo

Frequently asked questions — HCPCS J3230

What does HCPCS code J3230 describe?

J3230 is defined by CMS as "Injection, chlorpromazine hcl, up to 50 mg". Each billing unit represents 50 MG, so the units reported on the claim must equal the dose administered divided by that unit.

What is the Medicare reimbursement for J3230 in October 2026?

The ASP-based payment limit is $16.802 per 50 MG, with 20% beneficiary coinsurance. Medicare Administrative Contractors apply this limit; commercial payers use their own fee schedules. The July 2026 limit was $18.143.

How many units of J3230 can be billed per day?

The practitioner Medically Unlikely Edit is 2 units per date of service with adjudication indicator 3 (3 Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J3230?

The October 2026 ASP crosswalk lists 14 NDCs from 8 labelers: Chlorpromazine HCl (Henry Schein Inc.); Chlorpromazine HCl (Hikma Pharmaceuticals USA Inc.); Chlorpromazine Hcl (Dr. Reddy's Laboratories Inc.); Chlorpromazine HCl (HF Acquisition Co. LLC, DBA HealthFirst). For example NDC 00404-9836-01 is a 1 package equal to 1 billing unit. The crosswalk's billing-units-per-package figure converts each package into J3230 units.

Does J3230 have NCCI bundling edits?

No active practitioner PTP pairs list J3230 as a column-1 or column-2 code in the v323r0 release. Unit limits (MUE) and medical-necessity coverage rules still apply.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B and the Medicare Coverage Database. Payment limits are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.